| Literature DB >> 28781769 |
Abstract
Neisseria meningitidis is a harmless commensal bacterium finely adapted to humans. Unfortunately, under "privileged" conditions, it adopts a "devious" lifestyle leading to uncontrolled behavior characterized by the unleashing of molecular weapons causing potentially lethal disease such as sepsis and acute meningitis. Indeed, despite the lack of a classic repertoire of virulence genes in N. meningitidis separating commensal from invasive strains, molecular epidemiology and functional genomics studies suggest that carriage and invasive strains belong to genetically distinct populations characterized by an exclusive pathogenic potential. In the last few years, "omics" technologies have helped scientists to unwrap the framework drawn by N. meningitidis during different stages of colonization and disease. However, this scenario is still incomplete and would benefit from the implementation of physiological tissue models for the reproduction of mucosal and systemic interactions in vitro. These emerging technologies supported by recent advances in the world of stem cell biology hold the promise for a further understanding of N. meningitidis pathogenesis.Entities:
Keywords: N. meningitidis; Neisseria meningitidis; genomics; omics; pathogenesis
Year: 2017 PMID: 28781769 PMCID: PMC5531161 DOI: 10.12688/f1000research.11279.1
Source DB: PubMed Journal: F1000Res ISSN: 2046-1402
Figure 1. From colonization to dissemination: graphical representation of Neisseria meningitidis pathogenesis.
( A) N. meningitidis is spread by exchanging respiratory and throat secretions during close contacts between individuals. ( B) It then gets access to the nasopharynx, where it adheres to the mucosae of the mucociliary epithelium and resides as a commensal microorganism until environmental conditions are suitable for dissemination. ( C) Crossing of the mucosal epithelial barrier occurs by intra- or inter-cellular routes allowing entry into the bloodstream, where it quickly proliferates. This event causes sepsis and eventually (after translocation of a further physiological barrier such as the blood-brain barrier) meningitis. The right bottom panel is a list of factors/pathways defined by functional genomics studies to be determinant during various steps of N. meningitidis pathogenesis such as colonization of the nasopharynx and survival in blood. App, adhesion and penetration protein; fHbp, factor H-binding protein; FNR, fumarate and nitrate reductase regulator protein; Fur, ferric uptake regulation protein; Hfq, cofactor RNA-binding protein; LPS, lipopolysaccharide; MIP, macrophage infectivity potentiator MspA, meningococcal serine protease A; NadA, Neisseria adhesin A; NalP, Neisseria autotransporter lipoprotein; NhhA, Neisseria hia homologue A; NspA, Neisserial surface protein A; Opa, opacity protein; Opc, opacity protein C; sRNA, small non-coding RNA.
List of in vitro three-dimensional tissue models that could be exploited in studying Neisseria meningitidis colonization and pathogenesis.
| Nasopharynx | |
|---|---|
|
|
|
| Marrazzo
| 3D reconstruction of the human tracheo-bronchial mucosa comprehensive of the
|
| Kuehn
| Culture of the organotypic tissue bronchial and nasal culture model to study the impact of
|
| Steinke
| An engineered 3D human airway mucosa model based on a small intestine submucosa to
|
| Harrington
| Exploitation of biomimetic porous electrospun scaffolds to develop an immunocompetent 3D
|
| Nguyen Hoang
| Development of a method to generate a 3D organotypic model of the human airway mucosa in
|
| Pageau
| 3D
|
| Choe
| Human bronchial mucosal model, including a well-differentiated epithelium with functional cilia,
|
| Paquette
| Tissue-engineered human bronchial equivalents from biopsies of asthmatic and non-asthmatic
|
| Choe
| Tissue culture model of the human airway wall that can be induced to undergo matrix
|
| Paquette
| Production of tissue-engineered 3D human bronchial models at the air-liquid interface |
| Chakir
| To evaluate the feasibility of an engineered human bronchial mucosa as a model to study
|
|
| |
|
|
|
| Phan
| Extensive review of microphysiological systems capturing the complexity of the blood–central
|
| Wang
| Development of a microfluidic BBB model by deriving brain microvascular endothelial cells
|
| Herland
| Micro-engineering of a 3D model of the human BBB within a microfluidic chip by creating a
|
| Cho
| Construction of a 3D model of BBB on a microfluidic platform |
| Brown
| Development of a microfluidic device comprised of a vascular chamber and a brain chamber
|
| Deosarkar
| Development of a BBB on a chip comprising a tissue compartment and vascular channels
|
|
| |
|
|
|
| Hoch
| Extensive review of bioprinting of artificial blood vessels for 3D tissue engineering |
| Kolesky
| 3D bioprinting method for fabricating engineered tissue constructs replete with vasculature,
|
| Miller
| Rigid 3D filament network of carbohydrate glass used as a cyto-compatible sacrificial template
|
References are reported in chronological order and grouped by organ/tissue specificity. 3D, three-dimensional.